← Company directoryNASDAQ · SEC EDGAR
Cytosorbents Corporation
CTSOA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
SHARE PRICE · INDICATIVE——
A recent price could not be verified. Check the exchange before trading.
ANALYSIS ROUTE
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
CytoSorbents 1-for-20 reverse stock split
CytoSorbents common stock will undergo a 1-for-20 reverse split effective 8 September. The CTSO ticker will remain unchanged and the new CUSIP will be 23283X305.
Nasdaq ↗More NASDAQ records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
CTORCitius Oncology, Inc. NASDAQ · SEC→CTRMCastor Maritime Inc. - Common SharesNASDAQ · SEC→CTRNCiti Trends, Inc.NASDAQ · SEC→CTSHCognizant Technology Solutions CorporationNASDAQ · SEC→CTWCTW - Class A Ordinary SharesNASDAQ · SEC→CTXRCitius Pharmaceuticals, Inc.NASDAQ · SEC→CUBLionheart Holdings - Class A Ordinary SharesNASDAQ · SEC→CUBWULionheart Holdings - UnitNASDAQ · SEC→
DATA STATUS
Open official filings ↗Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.